Innovage/$INNV
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Innovage
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.
Ticker
$INNV
Sector
Primary listing
Industry
Health Care Providers & Services
Headquarters
Employees
2,350
ISIN
US45784A1043
Website
Innovage Metrics
BasicAdvanced
$532M
-
-$0.24
0.55
-
Price and volume
Market cap
$532M
Beta
0.55
52-week high
$6.61
52-week low
$2.60
Average daily volume
32K
Financial strength
Current ratio
0.782
Quick ratio
0.663
Long term debt to equity
12.793
Total debt to equity
39.367
Interest coverage (TTM)
-3.42%
Profitability
EBITDA (TTM)
-2.554
Gross margin (TTM)
69.09%
Net profit margin (TTM)
-3.75%
Operating margin (TTM)
-2.89%
Effective tax rate (TTM)
-5.90%
Revenue per employee (TTM)
$350,000
Management effectiveness
Return on assets (TTM)
-2.82%
Return on equity (TTM)
-11.51%
Valuation
Price to revenue (TTM)
0.642
Price to book
2.24
Price to tangible book (TTM)
5.79
Price to free cash flow (TTM)
33.413
Free cash flow yield (TTM)
2.99%
Free cash flow per share (TTM)
11.79%
Growth
Revenue change (TTM)
12.19%
Earnings per share change (TTM)
5.71%
3-year revenue growth (CAGR)
6.05%
3-year earnings per share growth (CAGR)
37.47%
What the Analysts think about Innovage
Analyst ratings (Buy, Hold, Sell) for Innovage stock.
Bulls say / Bears say
InnovAge has demonstrated significant revenue growth, with a 12.4% increase to $205.1 million in Q1 2025 compared to the previous year, indicating strong operational performance. (Investing.com)
The company has successfully lifted previous sanctions by improving documentation processes, allowing for new member enrollments and potential market expansion. (Investing.com)
InnovAge has strengthened its leadership team by appointing Michael Scarbrough as President and COO, bringing over 30 years of healthcare experience, which could enhance strategic direction and operational efficiency. (StockTitan)
InnovAge's stock reached a 52-week low of $3.5 in January 2025, reflecting investor concerns and potential market challenges. (Investing.com)
The company reported a net loss of $5.7 million in Q1 2025, despite revenue growth, indicating ongoing profitability challenges. (Investing.com)
InnovAge investors reached a settlement in a lawsuit alleging false statements in IPO registration documents, which could impact the company's reputation and financial standing. (Bloomberg Law)
Data summarised monthly by Lightyear AI. Last updated on 7 Jun 2025.
Innovage Financial Performance
Revenues and expenses
Innovage Earnings Performance
Company profitability
Innovage News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Innovage stock?
Innovage (INNV) has a market cap of $532M as of June 27, 2025.
What is the P/E ratio for Innovage stock?
The price to earnings (P/E) ratio for Innovage (INNV) stock is 0 as of June 27, 2025.
Does Innovage stock pay dividends?
No, Innovage (INNV) stock does not pay dividends to its shareholders as of June 27, 2025.
When is the next Innovage dividend payment date?
Innovage (INNV) stock does not pay dividends to its shareholders.
What is the beta indicator for Innovage?
Innovage (INNV) has a beta rating of 0.55. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.